JOHN MORRISON SMITH
It is difficult to appreciate today the feeling of helplessness I remember just over 30 years ago when, having recently obtained a senior appointment, I was consulted by an intelligent young man with severe asthma. He had failed to respond to bronchodilators and his distress was such as to threaten his otherwise happy and successful family and business life. It was apparent to me, and to him, that my scanty teaching on the subject as an undergraduate and even 11 years' experience in practice had not prepared me for this problem. I did not lack interest in respiratory disease or indeed in allergy. I had developed hay fever myself while a medical student and had some difficulty in finding anyone who knew what it was. This seems very curious in retrospect, for now hay fever is a matter of common knowledge.
I do not think that any of my teachers were aware of the experimental researches on the cause and nature of hay fever published by Charles Blackley in 1873. His book describing his careful work associating hay fever with grass pollen was almost certainly long out of print when I was a student. It was reprinted in 1959.' Today asthma is one of the commonest conditions seen in chest clinics and I wonder where all these patients went 30 or 40 years ago. Journals concerned with respiratory disease now print many articles related to asthma but this was not always so.
Asthma has gained literary respectability owing mainly, in my view, to advances in treatment. Much the same thing happened with tuberculosis.
Death is another stimulus to interest and when writing about this in 19662 I was conscious that I would probably precipitate other work-such as that of Speizer and others in 19683 and many others after them. Some of the relative lack of interest before about 1966 could be explained by the common belief and teaching that asthma was very rarely fatal. The possible association between unexpected deaths in young asthmatics and overuse of isoprenaline aerosols was also giving rise to considerable interest at the time. In retrospect we can see that deaths from chronic bronchitis and emphysema also rose in the 1960s, but the rise in deaths from asthma in young people caused most interest. We have never had an entirely convincing explanation of this temporary phenomenon although we have not lacked theories.45 ephedrine, which were popular, and aminophylline and isoprenaline, which were less popular. I also remember Brovon, a combination of adrenaline, atropine, and papaverine, which is still used. Neither Brovon nor any similar preparations, originally delivered by nebulisers operated by a simple hand bulb, were to my knowledge suspected of being harmful or likely to be overused. Isoprenaline solution cost very little and almost the only practical problem was that the little glass nebuliser parts tended to become blocked and could easily be broken. The patient needed to keep at least one replacement available. In the past stramonium leaf and potassium nitrate were inhaled either by burning them in a dish or smoking them in an "asthma cigarette." Such asthma cigarettes were certainly available in chemists' shops 40 years ago. They apparently gave short-lived relief and seem to reflect the poverty of effective remedies in the period. Many curious proprietory remedies were sold, some of which still exist and remain popular with certain patients.
Although adrenaline dated back to the experiments of the physiologists Oliver and Schafer at the end of the last century on extracts of the adrenal gland6 it was probably undervalued for many years, but it had become widely used in acute asthma by my student days. Going back a bit further, Berkhart in 19117 clearly preferred morphine for acute asthma, and even Cooke in 19238 wrote that "morphine acts more slowly, but more thoroughly, and is of the greatest use when the attack is fully developed and refuses to yield to any ordinary measures." He went on to say that "there is not the easy return to normal after morphine that sometimes obtains after adrenaline." Such ideas may be slow to go completely and it was not until after I was in practice that I truly appreciated the dangers of morphine and other sedatives in acute asthma. Measurement Specific treatment I do not recall any teaching about the specific treatment of allergic asthma, although I may have had some advice about avoiding domestic pets and flowers. This is perhaps unusual since hyposensitisation treatment had been introduced for hay fever and pollen asthma in 1911 by Leonard Noon" (fig  2) . The original idea was that hay fever, being an idiosyncratic reaction to a toxin in grass pollen, could be controlled by producing an antitoxin as a result of repeated small inoculations of pollen extract. This mistaken oversimplification was understandable in the climate of that time, when great advances were being made in the control of bacterial infection. Undoubtedly hopes were raised, which to a large extent went unfulfilled and led to a reaction of ill-informed scepticism about allergic disease. My student teaching of 40- general reactions occurred. In the early 1950s I used very long courses of similar aqueous extracts, obtained commercially. They were of essentially two types, grass pollen extract and house dust extract. I also used some mould extracts, mainly those of Cladosporium herbarum, but I did not use the complicated extracts made up from the many substances to which the patient reacted on skin testing. My course of injections was based on skin-test results and on a clinical history. After a few years I gradually abandoned this method of treatment, perhaps more from a general disillusionment than as a result of the clinical trials which I had carried out myself and others reported in the journals. I had an impression that after long courses of weekly injections some patients began to get local reactions lasting a week or more and also suffered clinical deterioration. Was an undesirable antibody being produced? The object was to block the allergic reaction, not to enhance it. Measurements of "blocking antibody" vary from the simple skin test of Kate Maunsell'2 to measurements of histamine release from cells and immunoglobulin assays. The skin test method consisted of mixing serial dilutions of the patient's own serum with a fixed amount of allergen extract and doing a series of intradermal skin tests. It could thus be shown that the patient's serum at a certain concentration would inhibit the skin reaction and must therefore contain a "blocking antibody." This was heat stable whereas the reagenic antibody giving the passive transfer reaction was heat labile. This "blocking antibody" was produced by a course of hyposensitisation, but did not bear any relation to clinical improvement.
Interest in food allergy has a very long history and has always had its devotees. In my early years these were few but recently this interest has been increasing with the possibility of blocking allergic reactions in the gut by pharmacological means. Foremost among the early enthusiasts was Albert Rowe, who had been drawn to this subject by his personal experience of illness precipitated by foods. His exclusion diets contained many recipes which could be helpful and very pleasant. Most clinicians, although aware of the occasional patient with dramatic immediate reactions to food, were reluctant to accept that the methods used by such enthusiasts could have a wide application in asthma.
Possibly the practical difficulties also acted as a deterrent.
Psychological aspects and treatment
When I was a student in the late 1930s and for many years afterwards asthma was considered by many of the most influencial medical teachers to be largely psychosomatic in origin. Such an attitude towards a disease reflects a lack both of understanding of the basic mechanisms in the pathogenesis and of effective treatment. Much was written about the emotional aspects of tuberculosis long after the tubercle bacillus had been identified but before specific treatment was available. Even as late as 1964, at a meeting on the nature of asthma, Dr DA Williams and his colleagues considered that psychological factors played a part in the causation of 70% of the 487 cases studied, although in only 1.2% did they consider the cause to be entirely psychological. '3 This attitude towards asthma, a chronic condition which undoubtedly gave rise to emotional distress, was transmitted not only to doctors at an early and impressionable stage in their lives but also to patients and their families. The impression, not usually expressed directly, that the patient was in some degree responsible for the distress of his own illness was widespread. It may have been most evident with children, and as more effective treatment became available it may have made some doctors reluctant to make full use of new developments and some patients to seek appropriate treatment. There has been a gradual change but perhaps some elements of this attitude still persist. I remember some 20 years ago spending a week observing the work of the asthma clinic at the Maudsley Hospital through the kindness of Dr Denis Leigh. My impressions were that the standard of general medical care given to the patients was very high but that the methods of psychotherapy used were too time consuming to be used in most hospitals for such a common disease.
One method which did for a time receive considerable interest was hypnosis. I myself took part in the first attempted clinical trial of hypnosis in children with the help of Dr Charles Burns, the pioneer of child psychiatry in Britain.'4 Neither this nor later studies showed convincingly successful results but there remained an impression that some patients did benefit. My own interest was not sustained, partly because I found the method laborious and time consuming.
Breathing exercises and special schools For many years a popular publication on the subject of asthma was a small booklet of instructions on breathing exercises produced for the Asthma Research Council by Dr James Livingstone. These exercises were aimed at relaxed breathing with use of the diaphragm. Many children received instruction on breathing that probably had limited value but was certainly preferable to unreasonable prohibitions relating to exercise.
The availability of more effective drug treatment has reduced interest in physiotherapy. Some of the larger local education authorities maintained special schools, both day and residential, which from about 1950 to 1970 accepted many asthmatic children. Most of these schools were originally opened for "delicate" children. Such children might have been suffering from anything from simple malnutrition to primary tuberculosis, while other schools were devoted entirely to specific physical handicaps such as rheumatic heart diseas, .
In recent years the number of asthmatic children admitted to such special schools has greatly diminished, their places often being taken by children classified as "maladjusted." With the increasing effectiveness of medical treatment the aim has been more and more to maintain children with asthma at normal schools and to allow as little interference as possible with their education and their ability to earn a living in the future. There has also been some change in the general attitude to exercise. Much, of course, has been written about exercise-induced asthma but the interest is mainly physiological and sport is now generally encouraged.
Special clinics for asthma
Thirty years ago special clinics for asthma were uncommon. Those that existed did so usually because some individual physician or paediatrician was particularly interested in the disease. Chest clinics in general were busy with tuberculosis and very few of the chest physicians of that time had an interest in asthma. Diagnosis was uncertain and both adults and children with asthma were frequently classified as suffering from chronic bronchitis and treated with antibiotics. Not until tuberculosis ceased to provide most of the work of chest clinics did asthma receive more attention. Other factors played a part in this development-in particular, the better understanding of pulmonary physiology, the availability of dry spirometers in clinics, and access to departments of respiratory physiology. The other major stimulus was the improvement in treatment. General practitioners were more inclined to seek specialist advice when this would provide help with effective treatment.
Whereas before 1960 asthma clinics were usually run by physicians with an interest in some special aspect such as the allergic or the psychological aspects of the condition, the later clinics tended to be mainly oriented to the therapeutic relief of symptoms, with occasionally a major interest in pulmonary physiology. There 1963.18 In the chapter on asthma I found these statements: "Most patients with long-standing asthma develop bronchitis"; "chronic anoxic pulmonary heart disease (cor pulmonale) becomes an important, and probably an inevitable, accompaniment of the chronic case in old age." This reflects the current opinion of the pathology of asthma and we owe a debt to Professor Jethro Gough, who as a result of applying the Gough and Wentworth paper section technique was able to show that the usual ideas on the pathology of asthma were mistaken to a large extent. Rereading one of his papers"9 reminded me both of the clarity of his work and of his likeable and unassuming character. The realisation of the essentially non-destructive pathology of asthma had an important influence on the attitude of clinicians. It made them try harder.
"Recent" is difficult to date in the present context, but 1967 stands out in my mind for several reasons. At this time an entirely new form of treatment, disodium cromoglycate, became available and important papers appeared throwing new light on allergic mechanisms in asthma. The discovery of IgE by the Ishizakas20 and almost simultaneously by Johansson and Bennich,2' who recognised a myeloma protein as belonging to a previously unknown class of immunoglobulin (later shown to be virtually identical with reagenic antibody22), has probably had relatively little impact on treatment in general but may yet have an important effect on the success of specific treatment. The other discovery in 1967, by Voorhorst and others,23 was that house dust mites were the principal source of house dust allergen, and this has had a more direct effect. Curiously, the work of Herman Dekker of Munich, who made similar observations in 1928,24 was overlooked until the Dutch workers published their findings. The first question about the house dust mite allergen was whether it had clinical significance.25 There is now no serious doubt about this. The impact on treatment has, however, been less than was at first hoped. Although a useful reduction in exposure to this allergen is fairly certain to come from admission to hospital or going to a high-altitude resort it is very difficult to alter most domestic environments sufficiently to make any clinical difference to mite-sensitive patients.
It Thus from about 1967 onwards the conditions existed for a considerable improvement in the treatment of asthma. Chest physicians had both time and resources available. Physiological assessment had greatly improved. New and effective drugs were becoming increasingly available and some at least of the prejudices of the past were being replaced by a more positive attitude towards the treatment of the disease. The only rather disappointing aspect was that advances in basic knowledge had not led to corresponding advances in specific treatment.
Systemic corticosteroids
The use of corticosteroids in asthma is not "recent" in that it dates back to about 1950. There was, however, confusion and disagreement about the use of this form of treatment for at least 10 years. Even much later there was was no uniformity of practice in the use of these drugs. This does seem curious since the introduction of steroid treatment has probably done more than anything else to give relief to those suffering from asthma. My own first experience of this treatment was in a schoolboy with chronic intractible asthma to whom I gave depot injections of adrenocorticotrophic hormone with limited benefit. He had had a clear chest radiograph before treatment and within two weeks a further film showed a mid-zone shadow. My first thought was that I had precipitated tuberculosis but in a further week his x-ray film was clear again and I was greatly relieved.
We did seem to be unduly conscious of possible ill effects and it was some years before I felt confident enough to publish a paper on long-term steroid treatment in asthmatic children, concluding that considerable improvement in the quality of life could be obtained in most cases by using relatively small oral doses of prednisolone with little clinical evidence of adrenal suppression, only occasional obvious deterioration of growth, and an absence of disastrous events attributable to The fact that Altounyan himself suffered from allergic asthma enabled him to save time and money by carrying out experiments on himself using a series of compounds produced by the chemists. Some of these were inactive and some frankly dangerous. The experiments consisted of attempts to treat, and later to prevent, deliberately provoked attacks. Although DSCG has proved to be one of the safest drugs in medicine many of the experiments carried out in the course of its development were far from safe. As a boy Altounyan was highly atopic and experienced at first hand, and at considerable expense to his family, all the inadequacy and some of the lack of sympathy with which medicine approached his afffictions in his childhood. It is perhaps his personal and financial misfortune which we have to thank for the development of this drug.
To be concerned with an early clinical trial of an entirely new drug is an exciting and anxious experience, particularly when it is used in children. My personal friendship with Dr Altounyan allowed me to be among the first to use DSCG in children.
The analysis of the results of the double-blind, controlled trial was attended by a degree of tension. Clearly the clinical effect was not so strong that one could guess at the result from knowing the patients. We had to collect and analyse the records carefully in the presence of Altounyan himself. I can still recall our relief and pleasure when the trial showed significant benefit from treatment, and the enjoyable meal that followed. Less enjoyable was the laborious preparation of the paper for publication in the face of understandable editorial caution. 33 So DSCG came into general use and made a particularly important impact in childhood, reducing by about half the number of children who required long-term steroids. A voluminous body of papers, both clinical and experimental, culminated in the symposium on the mast cell held in Davos in 1979, during which the clinical applications and experimental work on the compound were thoroughly discussed.
Many related compounds have been developed by the pharmaceutical industry. Some have been active orally, and some appear to be many times more active than DSCG in laboratory studies. Strangely, none of these other compounds has so far proved to be so successful and acceptable in clinical use in man.
Inhaled cortiocosteroids
Like many others in the early days of steroid treatment, I had hoped that local application in the bronchi would be effective in relieving asthma without giving rise to systemic effects. Almost the only available preparation was hydrocortisone hemisuccinate and the solution had to be nebulised by a hand nebuliser with a rubber bulb. It In the United Kingdom I do not believe that chest physicians and paediatricians have been at all anxious about whether inhaled steroids cause adrenal suppression because their clinical experience has been that children sucessfully controlled on inhaled steroids in place of the previous oral steroids lost any cushingoid features, looked well, and were usually found to be growing better. In the United States this satisfaction with the general safety of inhaled steroids and in particular the lack of adrenal suppression in long-term use has been challenged on experimental grounds,38 but clinical experience is likely to prove to be of greater weight in determining clinical practice.
For the past 10 years beclomethasone dipropionate has been by far the most commonly used inhaled steroid. Other such drugs with a high degree of local action and minimal systemic action have been developed and may challenge the position of BDP. Betamethasone 17-valerate was also used for its local action initially in dermatology, as was BDP, but although it has been available for just as long and has been shown to be effective in asthma it has not gained the same popularity.
The combined effect of the development of DSCG and BDP was to reduce considerably the number of patients taking oral steroids. With both drugs there was a serious problem of compliance. This did not usually apply during the initial trials but it was certainly a problem in general use. Though good intelligence and family background may help,38 the problem of non-compliance is common to many long-continued treatments. There is no doubt that inhaled treatment for asthma, which is more troublesome than oral treatment, has been subject to this difficulty. It could be only partly overcome by clear, repeated instructions and constant encouragement, and by improved design of inhalation devices. The Spinhaler for inhalation of DSCG has remained essentially unchanged since its development by Dr Altounyan with the help of the aeronautical department at Loughborough University, but the equivalent device for inhalation of BDP in powder form was modified several times. Originally inhaled steroids were incorporated in a pressurised aerosol, but as not all patients managed aerosols properly BDP was supplied in powder form in capsules. The Rotahaler device for inhaling these capsules in its original form had several drawbacks. The later and improved model was simpler and more certain in operation. It could be used easily in the dark and had no parts likely to deteriorate quickly.
Bronchodilators
The first of the synthetic sympathomimetic drugs was isoprenaline, introduced in 1940 and available in a pressurised aerosol after 1950. The general anxiety over the deaths from asthma in the late 1960s resulted in regulations requiring bronchodilator aerosols to be supplied only on prescription by a doctor, whereas until 1967 they could be bought freely in a pharmacy. Aerosol propellants are said to be unlikely to be dangerous in clinical practice40 and isoprenaline itself was not suspect when used with a hand bulb nebuliser. A new, generation of more specific,8-stimulants introduced from 1967 onwards have almost completely displaced isoprenaline in clinical practice. Those in most frequent use have been salbutamol and terbutaline. In the case of salbutamol there has been a further change in the method of delivery with the development of the powder form in a capsule taken by means of the Rotahaler device used for BDP. As with BDP, this has generally resulted in a higher unit dose, although not necessarily a higher daily dose. For some patients there is an advantage in the powder form since they are not required to synchronise their inhalation with the brief discharge of a pressurised aerosol. The convenience of the pressurised aerosol has, however, ensured its continued popularity for the delivery of bronchodilators.
In hospital practice the use of drugs such as salbutamol solution administered via Wright's nebuliser (or its equivalent) driven either by oxygen or by a small electric air pump has become increasingly popular and to some extent has replaced the intravenous use of the same drugs and even intravenous aminophylline. For many years domestic use of electric nebulisers with bronchodilator solutions such as isoprenaline and later the more specific /3-stimulants was common in European countries. Children who had been treated in Switzerland became accustomed to using such nebulisers on demand if they were awakened by dyspnoea at night or had an attack while playing a vigorous game. Their parents often asked their doctors to prescribe such a device when the children returned home, only to be met with a blunt refusal or the problem of obtaining suitable machines in England, particularly on the National Health Service. There has been much more interest in this method of treatment recently and several excellent electric aerosol machines are available. My own practice for almost 30 years was to use isoprenaline (or more recently salbutamol) in a Wright's nebuliser driven by an oxygen cylinder and timed, for children, to half a minute with a sand glass.
The simplest form of administration of any drug is to swallow a small tablet, and oral bronchodilators are still widely used even though much higher doses are required than those given by inhalation, leading to more side effects. The tablets combining ephedrine, aminophylline, and phenobarbitone, once so popular, are no longer much used. Ephedrine has declined greatly in use in recent years and I rarely prescribe it now, whereas before about 1967 I did so very frequently indeed. Rather surprisingly, oral theophylline preparations have in the recent past enjoyed increased popularity, particularly in the form of long-acting tablets. This has been associated with an enthusiasm for measuring blood concentrations of theophylline where such measurements are possible. Theophylline has always been more popular in North America and the newer bronchodilator drugs were not accepted by the United States authorities for some years after they came into general use in the United Kingdom. The popularity of theophylline preparations by mouth seems unlikely to be sustained, but the limited use of aminophylline suppositories may continue despite a national dislike of this form of administration.
Immunotherapy
Recent years have not been particularly fruitful in respect of important advances in specific treatment of allergic disease despite much new knowledge about immunological mechanisms and mediators of allergic reactions. The main advances have been the greater ease and safety of treatment achieved by modification of extracts of allergens. These extracts have been treated in much the same way as diphtheria toxin is treated to produce a toxoid. The other aim has been to give an equivalent protective effect with smaller doses by delaying absorbtion and destruction of the allergen. The use of oil and silicone emulsions for this purpose proved unsatisfactory owing to their instability and uncertainty in clinical use and the occurrence of local granulomas and chronic ulcers at the site of injection. I tried them all on myself and on a few patients. I had no disastrous results but was not impressed with the benefit. Tyrosine has been used to adsorb allergen extracts and delay release without fear of local ulceration and it has been more successful. The search for a means of modifying allergens to obtain protection without danger goes on.
Another line of research has been the purification of allergens. The most successful practical example of this is the "antigen E" obtained from ragweed by King and 
